Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here comes the selling pressure these license announcements bring.

Agreed. Announcements give them a small market to sell into.

Look at the volume. Shorts aren't going to screw around with a 20 cent stock that trades 400K shares. There is little profit potential. Anyone shorting from much higher prices would have covered by now. There's no point trying to squeeze an extra few pennies out of an existing short position and too much risk in starting one in a low volume sub-20 cent stock with an operating company behind it.

There are far more fertile pastures. Anyone who thinks there is a huge short attack on PTSC right now is probably also wearing a tinfoil hat. There may have been at one point but not any more. It's a spent husk.











Share
New Message
Please login to post a reply